ProMIS Neurosciences Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMN and other ETFs, options, and stocks.

About PMN

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.

CEO

Neil K. Warma

CEONeil K. Warma

Employees

Employees7

Headquarters

Toronto, Ontario

HeadquartersToronto, Ontario

Founded

2004

Founded2004

Employees

Employees7

PMN Key Statistics

Market cap

18.78M

Market cap18.78M

Price-Earnings ratio

5.60

Price-Earnings ratio5.60

Dividend yield

—

Dividend yield—

Average volume

32.40K

Average volume32.40K

High today

$0.603

High today$0.603

Low today

$0.56

Low today$0.56

Open price

$0.57

Open price$0.57

Volume

20.90K

Volume20.90K

52 Week high

$2.37

52 Week high$2.37

52 Week low

$0.5111

52 Week low$0.5111

ProMIS Neurosciences Inc.

Why Robinhood?

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. Show more

PMN Key Statistics

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.